Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,4.156758415686885e-06,4.0793668612483165,50.54651697910897,"['RPL41', 'RPS8', 'RPL23', 'RPLP0', 'RPL23A', 'RPL10A', 'RPS6KA3', 'RPS15A', 'RPS27', 'RPS6KA2', 'RPL37A', 'RPL35', 'RPL13', 'RPS20', 'RPL29', 'RPL39', 'RPS24', 'RPS12']",0.0015961952316237637,0,0,18
2,IL-4 signaling pathway WP395,0.001772448082551167,3.7156552779194287,23.540138632268604,"['NFKBIA', 'HRH1', 'IRS1', 'SHC1', 'INPP5D', 'EP300', 'FLNA', 'IRS2', 'JAK1']",0.34031003184982406,0,0,9
3,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.013911696839878107,2.7722704431247145,11.851526264602336,"['CACNG7', 'SGCD', 'ACTN2', 'CTNNA1', 'ITGA7', 'CACNA1D', 'CTNNA2', 'ACTG1']",0.9682678160400457,0,0,8
4,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.018162432123514545,4.68,18.759311940424396,"['SMAD2', 'SHC1', 'FLNA', 'NR2C2']",0.9682678160400457,0,0,4
5,Eicosanoid Synthesis WP167,0.02044032691588124,6.513643659711075,25.339673065070055,"['TBXAS1', 'PLA2G5', 'PTGDS']",0.9682678160400457,0,0,3
6,Iron metabolism in placenta WP2007,0.02044032691588124,6.513643659711075,25.339673065070055,"['FTH1', 'ACO1', 'MCOLN1']",0.9682678160400457,0,0,3
7,Somatic sex determination WP4814,0.02112712027777564,15.185785536159601,58.57457768963273,"['SOX8', 'PTGDS']",0.9682678160400457,0,0,2
8,Integrin-mediated Cell Adhesion WP185,0.023464087548636835,2.2107837768773044,8.2954890712401,"['VASP', 'VAV3', 'RAP1A', 'SHC1', 'CAPN5', 'CAPN2', 'ITGA7', 'TLN1', 'DOCK1', 'PAK4']",0.9682678160400457,0,0,10
9,Leptin Insulin Overlap WP3935,0.026834726918186908,5.698970037453184,20.619206698794265,"['IRS1', 'IRS2', 'DGKZ']",0.9682678160400457,0,0,3
10,miR-509-3p alteration of YAP1/ECM axis WP3967,0.026834726918186908,5.698970037453184,20.619206698794265,"['EDNRA', 'COL5A1', 'TEAD1']",0.9682678160400457,0,0,3
11,Sulfation Biotransformation Reaction WP692,0.04861299025283994,7.591645885286783,22.956108448383258,"['SULT1A1', 'GSR']",0.9682678160400457,0,0,2
12,Prostaglandin Synthesis and Regulation WP98,0.050444300032593724,3.2005263157894737,9.559605712438605,"['CBR1', 'EDNRA', 'TBXAS1', 'PTGDS']",0.9682678160400457,0,0,4
13,Pathways affected in adenoid cystic carcinoma WP3651,0.05632823526750991,2.174583258648503,6.255317815961903,"['FBXW7', 'UHRF1', 'NFIB', 'CHEK2', 'ATRX', 'EP300', 'DTX4']",0.9682678160400457,0,0,7
14,Constitutive Androstane Receptor Pathway WP2875,0.06159950092062348,3.7980649188514355,10.585592471979039,"['SULT1A1', 'NCOA1', 'DNAJC7']",0.9682678160400457,0,0,3
15,MAPK pathway in congenital thyroid cancer WP4928,0.06159950092062348,3.7980649188514355,10.585592471979039,"['ALK', 'GAREM2', 'SHC1']",0.9682678160400457,0,0,3
16,Mitochondrial complex III assembly WP4921,0.06159950092062348,3.7980649188514355,10.585592471979039,"['UQCRB', 'UQCR10', 'UQCRC2']",0.9682678160400457,0,0,3
17,Arylamine metabolism WP694,0.06191736872872067,inf,inf,['SULT1A1'],0.9682678160400457,0,0,1
18,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.06253210307688534,2.5346266166040885,7.026175597522721,"['CTNNA1', 'MAP4K5', 'TEAD1', 'ACTG1', 'PAK4']",0.9682678160400457,0,0,5
19,Interferon type I signaling pathways WP585,0.06281890445333083,2.282142857142857,6.315828587296328,"['EIF4A1', 'RAP1A', 'IRS1', 'IRS2', 'JAK1', 'PIAS1']",0.9682678160400457,0,0,6
20,Focal Adhesion WP306,0.06529155397739075,1.6301091892936515,4.448392892301446,"['VASP', 'VAV3', 'PDGFRB', 'PPP1R12A', 'SHC1', 'TESK2', 'ACTG1', 'RAP1A', 'CAPN2', 'FLNA', 'ITGA7', 'TLN1', 'DOCK1', 'PAK4']",0.9682678160400457,0,0,14
21,Ketogenesis and Ketolysis WP4742,0.06531576366765202,6.072817955112219,16.569816591152268,"['CPT2', 'OXCT1']",0.9682678160400457,0,0,2
22,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.07244811168697757,3.50561797752809,9.201842902907842,"['TBXAS1', 'PLA2G5', 'PTGDS']",0.9682678160400457,0,0,3
23,Ebola Virus Pathway on Host WP4217,0.07697107101378128,1.7507744868120096,4.489555886853903,"['GSN', 'CTSL', 'TYRO3', 'EP300', 'FLNA', 'RAB9A', 'IQGAP1', 'MFGE8', 'ACTG1', 'HLA-E']",0.9682678160400457,0,0,10
24,Wnt signaling in kidney disease WP4150,0.08248807043118755,2.6430434782608696,6.594662003367555,"['FZD3', 'FZD7', 'FZD9', 'WNT7A']",0.9682678160400457,0,0,4
25,Prolactin Signaling Pathway WP2037,0.08742560979375226,1.9363978555948442,4.718937713633222,"['NFKBIA', 'IRS1', 'SHC1', 'RPS6KA2', 'FLNA', 'IRS2', 'JAK1']",0.9682678160400457,0,0,7
26,Nuclear receptors WP170,0.09175047550449335,2.5327083333333333,6.04983635064396,"['THRB', 'NR2F1', 'RORA', 'NR2C2']",0.9682678160400457,0,0,4
27,"GPCRs, Class A Rhodopsin-like WP455",0.09339525288481071,1.9016624843161858,4.50867965390317,"['EDNRA', 'HRH1', 'GPR37', 'GPR35', 'GPER1', 'ADORA1', 'RRH']",0.9682678160400457,0,0,7
28,Integrated breast cancer pathway WP1984,0.09439326665054058,1.5897233201581027,3.7522009591752368,"['SMAD2', 'FER', 'RAP1A', 'RASGEF1A', 'IRS1', 'CHEK2', 'ODC1', 'NF1', 'EP300', 'BACH1', 'PIAS1', 'JAK1']",0.9682678160400457,0,0,12
29,Zinc homeostasis WP3529,0.10950606274288807,2.8476123595505616,6.298278862344993,"['SLC39A11', 'SLC30A1', 'SLC39A12']",0.9682678160400457,0,0,3
30,ATM Signaling Pathway WP2516,0.11166996679613919,2.3375,5.124284991193693,"['NFKBIA', 'CRADD', 'CHEK2', 'AP3B2']",0.9682678160400457,0,0,4
31,Regulation of Actin Cytoskeleton WP51,0.11372932567871138,1.565261458321057,3.402775087395163,"['CYFIP2', 'PDGFRB', 'ENAH', 'PPP1R12A', 'MRAS', 'GSN', 'IQGAP1', 'DOCK1', 'ACTG1', 'ARHGEF6', 'PAK4']",0.9682678160400457,0,0,11
32,NRF2 pathway WP2884,0.11542151346056008,1.6501022959763583,3.562842327137108,"['CBR1', 'SLC6A9', 'FTH1', 'TXNRD1', 'GSR', 'SLC39A11', 'SLC39A12', 'SLC5A3', 'PRDX6']",0.9682678160400457,0,0,9
33,Adipogenesis WP236,0.12121264648068389,1.630323450134771,3.4403230003736396,"['NCOA1', 'GDF10', 'IRS1', 'ASIP', 'NR2F1', 'IRS2', 'RORA', 'PLIN2', 'LPIN2']",0.9682678160400457,0,0,9
34,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.12228896076371017,2.2507407407407407,4.729635703142347,"['NFKBIA', 'PPP3CB', 'EP300', 'NELFA']",0.9682678160400457,0,0,4
35,Development and heterogeneity of the ILC family WP3893,0.12389115648089412,3.794576059850374,7.924410007252311,"['IL33', 'RORA']",0.9682678160400457,0,0,2
36,Energy Metabolism WP1541,0.12485065411890281,1.9997035768394704,4.16065729706126,"['NCOA1', 'PPP3CB', 'PRKAG1', 'EP300', 'NRF1']",0.9682678160400457,0,0,5
37,Ciliary landscape WP4352,0.13026425882898493,1.3854684070694236,2.8238480348840507,"['WDR26', 'TFAP2E', 'PSMD13', 'ARMC8', 'IQGAP1', 'BBIP1', 'LRPPRC', 'EXOSC7', 'AFG3L2', 'WNK1', 'EXOSC9', 'CDH23', 'BBS9', 'MCM5', 'EFHC2', 'SNAP29', 'CDR2']",0.9682678160400457,0,0,17
38,EPO Receptor Signaling WP581,0.13746840153197115,2.5307948397836038,5.022011073396359,"['SHC1', 'IRS1', 'IRS2']",0.9682678160400457,0,0,3
39,Dopaminergic Neurogenesis WP2855,0.14545926479192747,3.3726794125796618,6.502051029586821,"['ALDH1A1', 'GLI1']",0.9682678160400457,0,0,2
40,FOXA2 pathway WP5066,0.14545926479192747,3.3726794125796618,6.502051029586821,"['IRS1', 'IRS2']",0.9682678160400457,0,0,2
41,GPR40 Pathway WP3958,0.14545926479192747,3.3726794125796618,6.502051029586821,"['PLCE1', 'PLCD1']",0.9682678160400457,0,0,2
42,Mammalian disorder of sexual development WP4842,0.14545926479192747,3.3726794125796618,6.502051029586821,"['SOX8', 'PTGDS']",0.9682678160400457,0,0,2
43,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.147922905428825,1.7537593984962405,3.3515465391719483,"['PRKN', 'PSMD6', 'GPR37', 'FBXW7', 'PSMD13', 'HSPA2']",0.9682678160400457,0,0,6
44,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.1616651600987517,1.4768530972585654,2.6911630594095177,"['RPS6KA3', 'THRB', 'IRS1', 'SHC1', 'RPS6KA2', 'PRKAG1', 'IRS2', 'RICTOR', 'MAP4K5', 'RHOQ']",0.9682678160400457,0,0,10
45,Integrated Cancer Pathway WP1971,0.16865403732645162,1.9596774193548387,3.488041163053289,"['SMAD2', 'CHEK2', 'BACH1', 'JAK1']",0.9682678160400457,0,0,4
46,Rett syndrome causing genes WP4312,0.1741106516692571,1.7664522513607126,3.087872034795529,"['SYNGAP1', 'CDKL5', 'KCNJ10', 'IMPDH2', 'RHOBTB2']",0.9682678160400457,0,0,5
47,EV release from cardiac cells and their functional effects WP3297,0.17450102522907762,7.583437110834371,13.239351531720425,['KLF2'],0.9682678160400457,0,0,1
48,Fatty Acid Omega Oxidation WP206,0.17450102522907762,7.583437110834371,13.239351531720425,['ALDH1A1'],0.9682678160400457,0,0,1
49,Hypothetical Craniofacial Development Pathway WP3655,0.17450102522907762,7.583437110834371,13.239351531720425,['ARHGAP29'],0.9682678160400457,0,0,1
50,MED and Pseudoachondroplasia genes WP4789,0.17450102522907762,7.583437110834371,13.239351531720425,['COL9A2'],0.9682678160400457,0,0,1
51,PDGF Pathway WP2526,0.18109980864340952,1.89828125,3.243606404277799,"['PDGFRB', 'NFKBIA', 'SHC1', 'JAK1']",0.9682678160400457,0,0,4
52,Nuclear Receptors Meta-Pathway WP2882,0.18129375666860972,1.316614076004939,2.2482983819977673,"['NCOA1', 'CBR1', 'TXNRD1', 'GSR', 'SLC39A11', 'IRS2', 'SLC39A12', 'SLC5A3', 'PRDX6', 'SULT1A1', 'SLC6A9', 'CPT2', 'DNAJC7', 'FTH1', 'EP300', 'MFGE8']",0.9682678160400457,0,0,16
53,White fat cell differentiation WP4149,0.18323591457063362,2.1687176743356518,3.680272266379318,"['CTNNA1', 'RORA', 'KLF2']",0.9682678160400457,0,0,3
54,Translation Factors WP107,0.18475140696241726,1.7261633860507453,2.915048240197658,"['EIF4A1', 'EIF1AY', 'EIF3E', 'EIF3D', 'EIF4G3']",0.9682678160400457,0,0,5
55,Kit receptor signaling pathway WP304,0.19562235432058328,1.6876651369767766,2.7535425283190955,"['RPS6KA3', 'SHC1', 'INPP5D', 'EP300', 'MAPT']",0.9682678160400457,0,0,5
56,Wnt signaling pathway and pluripotency WP399,0.19856247428071486,1.5195734002509411,2.456620611526604,"['FZD3', 'RACGAP1', 'PPP2R2B', 'FZD7', 'FZD9', 'EP300', 'WNT7A']",0.9682678160400457,0,0,7
57,Resistin as a regulator of inflammation WP4481,0.19929901852899895,2.0699693564862103,3.3387549546546373,"['NFKBIA', 'PLCE1', 'PLCD1']",0.9682678160400457,0,0,3
58,Thermogenesis WP4321,0.20106538045469063,1.464914936126415,2.3499068886037286,"['RPS6KA3', 'SMARCC2', 'CPT2', 'RPS6KA2', 'PRKAG1', 'ADCY8', 'ACTG1', 'CREB5']",0.9682678160400457,0,0,8
59,Cell cycle WP179,0.20106538045469063,1.464914936126415,2.3499068886037286,"['SMAD2', 'STAG1', 'TFDP2', 'CHEK2', 'ORC3', 'CDC27', 'EP300', 'MCM5']",0.9682678160400457,0,0,8
60,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.20684408028230616,1.7863235294117648,2.814870763150864,"['DHX58', 'EP300', 'TRIM25', 'JAK1']",0.9682678160400457,0,0,4
61,Phytochemical activity on NRF2 transcriptional activation WP3,0.2136516300489737,2.528886118038238,3.9031042982273316,"['MAF', 'EPHB2']",0.9682678160400457,0,0,2
62,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.2136516300489737,2.528886118038238,3.9031042982273316,"['FZD7', 'DKK3']",0.9682678160400457,0,0,2
63,Androgen receptor signaling pathway WP138,0.2164194047841508,1.477119057577025,2.2607854672220467,"['NCOA1', 'EP300', 'FLNA', 'CALR', 'NR2C2', 'PLPP1', 'PIAS1']",0.9682678160400457,0,0,7
64,Notch Signaling Pathway Netpath WP61,0.21799543400383586,1.6155833089233882,2.4609876190727644,"['NOTCH2', 'FBXW7', 'FHL1', 'EP300', 'MAPT']",0.9682678160400457,0,0,5
65,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.223346779525261,1.518922305764411,2.276909572764012,"['FZD3', 'H2AFY2', 'FZD7', 'FZD9', 'WNT7A', 'CXXC4']",0.9682678160400457,0,0,6
66,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.2250884387801727,1.3815894797026873,2.0603117425198936,"['NOTCH2', 'SMAD2', 'FZD3', 'SHC1', 'PDCD6', 'FZD7', 'FZD9', 'WNT7A', 'NR2C2']",0.9682678160400457,0,0,9
67,Hippo-Merlin Signaling Dysregulation WP4541,0.2255589319577896,1.4567642357470652,2.169375154683034,"['PDGFRB', 'DDB1', 'PPP1R12A', 'CTNNA1', 'ITGA7', 'TEAD1', 'PAK4']",0.9682678160400457,0,0,7
68,Synthesis and Degradation of Ketone Bodies WP311,0.22562568190588472,5.055209630552096,7.526590038330122,['OXCT1'],0.9682678160400457,0,0,1
69,Tamoxifen metabolism WP691,0.22562568190588472,5.055209630552096,7.526590038330122,['SULT1A1'],0.9682678160400457,0,0,1
70,Alzheimer's disease WP2059,0.24392500889203744,1.4696822701916081,2.0735665458346197,"['BACE1', 'PPP3CB', 'CAPN2', 'ADAM10', 'CACNA1D', 'MAPT']",0.9682678160400457,0,0,6
71,Alpha 6 Beta 4 signaling pathway WP244,0.2491981596627308,1.821123595505618,2.5304637599624753,"['SHC1', 'IRS1', 'IRS2']",0.9682678160400457,0,0,3
72,Oncostatin M Signaling Pathway WP2374,0.25290521447093167,1.5182728410513142,2.087231174985857,"['NFKBIA', 'IRS1', 'SHC1', 'RICTOR', 'JAK1']",0.9682678160400457,0,0,5
73,Transcription co-factors SKI and SKIL protein partners WP4533,0.2605580073533924,2.1672604203776276,2.914813049166488,"['NF1', 'TEAD1']",0.9682678160400457,0,0,2
74,Triacylglyceride synthesis WP325,0.2605580073533924,2.1672604203776276,2.914813049166488,"['AGPAT3', 'PLPP1']",0.9682678160400457,0,0,2
75,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.2605580073533924,2.1672604203776276,2.914813049166488,"['EIF3E', 'EIF3D']",0.9682678160400457,0,0,2
76,Pregnane X receptor pathway WP2876,0.2605580073533924,2.1672604203776276,2.914813049166488,"['NCOA1', 'DNAJC7']",0.9682678160400457,0,0,2
77,Endoderm differentiation WP2853,0.2606239250763209,1.3501954215522054,1.8155764734703108,"['SMAD2', 'VAV3', 'ATP8B2', 'SESN1', 'NAA15', 'LRPPRC', 'PIAS1', 'PARP8']",0.9682678160400457,0,0,8
78,EGF/EGFR signaling pathway WP437,0.2642892381780214,1.2759546797839878,1.6979271529778837,"['VAV3', 'RPS6KA3', 'RAP1A', 'SHC1', 'RPS6KA2', 'INPP5D', 'PLCE1', 'AP2A1', 'RICTOR', 'IQGAP1', 'JAK1']",0.9682678160400457,0,0,11
79,Amino Acid metabolism WP3925,0.2650287548399434,1.4235197368421053,1.8903159872870439,"['RARS', 'ALDH1A1', 'ODC1', 'GSR', 'FAH', 'FARSB']",0.9682678160400457,0,0,6
80,"GPCRs, Other WP117",0.2662421176229677,1.750936329588015,2.317100134226088,"['EDNRA', 'GPR143', 'GRM8']",0.9682678160400457,0,0,3
81,PDGFR-beta pathway WP3972,0.2662421176229677,1.750936329588015,2.317100134226088,"['PDGFRB', 'SHC1', 'JAK1']",0.9682678160400457,0,0,3
82,TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer WP2868,0.2735877882052546,3.791095890410959,4.9137634584819105,['JAK1'],0.9682678160400457,0,0,1
83,Tgif disruption of Shh signaling WP3674,0.2735877882052546,3.791095890410959,4.9137634584819105,['SMAD2'],0.9682678160400457,0,0,1
84,Nucleotide GPCRs WP80,0.2735877882052546,3.791095890410959,4.9137634584819105,['ADORA1'],0.9682678160400457,0,0,1
85,Osteoblast Signaling WP322,0.2735877882052546,3.791095890410959,4.9137634584819105,['PDGFRB'],0.9682678160400457,0,0,1
86,SARS-CoV-2 and COVID-19 Pathway WP4846,0.2735877882052546,3.791095890410959,4.9137634584819105,['CTSL'],0.9682678160400457,0,0,1
87,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.27689950192559043,1.459637046307885,1.8743208763647243,"['FZD3', 'FZD7', 'FZD9', 'WNT7A', 'CXXC4']",0.9682678160400457,0,0,5
88,Transcription factor regulation in adipogenesis WP3599,0.28408830602841484,2.022610141313383,2.545394492849089,"['IRS1', 'IRS2']",0.9682678160400457,0,0,2
89,Methionine De Novo and Salvage Pathway WP3580,0.28408830602841484,2.022610141313383,2.545394492849089,"['CHDH', 'ODC1']",0.9682678160400457,0,0,2
90,Synaptic Vesicle Pathway WP2267,0.2890954760159394,1.517625,1.8833700125476558,"['RIMS1', 'CACNA1B', 'AP2A1', 'STX2']",0.9682678160400457,0,0,4
91,Type 2 papillary renal cell carcinoma WP4241,0.30068049624848536,1.625601926163724,1.9534972988279284,"['EGLN1', 'EP300', 'COL21A1']",0.9682678160400457,0,0,3
92,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.30068049624848536,1.625601926163724,1.9534972988279284,"['SMAD2', 'IRS1', 'RICTOR']",0.9682678160400457,0,0,3
93,Genotoxicity pathway WP4286,0.30327921323931323,1.4804878048780488,1.766372075570012,"['RPS27', 'BLOC1S2', 'PPM1D', 'TOPORS']",0.9682678160400457,0,0,4
94,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.3075430771640053,1.8960411471321696,2.235698172877952,"['EP300', 'ZFX']",0.9682678160400457,0,0,2
95,Purinergic signaling WP4900,0.3075430771640053,1.8960411471321696,2.235698172877952,"['GNAI3', 'ADORA1']",0.9682678160400457,0,0,2
96,IL-5 signaling pathway WP127,0.3179936858657331,1.5694175384218003,1.7981189508376727,"['SHC1', 'MAPT', 'JAK1']",0.9682678160400457,0,0,3
97,EDA signaling in hair follicle development WP3930,0.3185827479226385,3.0326276463262767,3.468940982606827,['GLI1'],0.9682678160400457,0,0,1
98,Genes targeted by miRNAs in adipocytes WP1992,0.3185827479226385,3.0326276463262767,3.468940982606827,['PTBP2'],0.9682678160400457,0,0,1
99,LDLRAD4 and what we know about it WP4904,0.3185827479226385,3.0326276463262767,3.468940982606827,['SMAD2'],0.9682678160400457,0,0,1
100,"Phase I biotransformations, non P450 WP136",0.3185827479226385,3.0326276463262767,3.468940982606827,['PON2'],0.9682678160400457,0,0,1
101,Pilocytic astrocytoma WP2253,0.3185827479226385,3.0326276463262767,3.468940982606827,['NF1'],0.9682678160400457,0,0,1
102,Sleep regulation WP3591,0.3308415466632874,1.784362622854628,1.9737115637553548,"['ADORA1', 'PTGDS']",0.9682678160400457,0,0,2
103,Genes controlling nephrogenesis WP4823,0.3308415466632874,1.784362622854628,1.9737115637553548,"['NOTCH2', 'PDGFRB']",0.9682678160400457,0,0,2
104,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.3308415466632874,1.784362622854628,1.9737115637553548,"['EGLN1', 'PRKAG1']",0.9682678160400457,0,0,2
105,miRNA regulation of p53 pathway in prostate cancer WP3982,0.3308415466632874,1.784362622854628,1.9737115637553548,"['ZMAT3', 'CHEK2']",0.9682678160400457,0,0,2
106,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.3318455674195073,1.4113953488372093,1.5568898522678207,"['DDX17', 'NFKBIA', 'DHX58', 'TRIM25']",0.9682678160400457,0,0,4
107,Aryl Hydrocarbon Receptor Netpath WP2586,0.335319083489668,1.5169787765293383,1.657561314490159,"['PLAGL1', 'NF1', 'EP300']",0.9682678160400457,0,0,3
108,Target Of Rapamycin (TOR) Signaling WP1471,0.335319083489668,1.5169787765293383,1.657561314490159,"['RRAGD', 'PRKAG1', 'RICTOR']",0.9682678160400457,0,0,3
109,Phosphoinositides metabolism WP4971,0.335319083489668,1.5169787765293383,1.657561314490159,"['INPP5D', 'PLCE1', 'PLCD1']",0.9682678160400457,0,0,3
110,IL-2 signaling pathway WP49,0.35262165475902785,1.4679231605654222,1.530103793172951,"['SHC1', 'MAPT', 'JAK1']",0.9682678160400457,0,0,3
111,7-oxo-C and 7beta-HC pathways WP5064,0.3539132089968299,1.6850928234968134,1.7503119285705506,"['ACOT9', 'AMACR']",0.9682678160400457,0,0,2
112,Signal Transduction of S1P Receptor WP26,0.3539132089968299,1.6850928234968134,1.7503119285705506,"['RACGAP1', 'GNAI3']",0.9682678160400457,0,0,2
113,Striated Muscle Contraction Pathway WP383,0.3539132089968299,1.6850928234968134,1.7503119285705506,"['ACTN2', 'ACTG1']",0.9682678160400457,0,0,2
114,Canonical and non-canonical Notch signaling WP3845,0.3539132089968299,1.6850928234968134,1.7503119285705506,"['NOTCH2', 'ADAM10']",0.9682678160400457,0,0,2
115,Immune response to tuberculosis WP4197,0.3539132089968299,1.6850928234968134,1.7503119285705506,"['PIAS1', 'JAK1']",0.9682678160400457,0,0,2
116,Canonical NF-KB pathway WP4562,0.36079390645232967,2.5269821502698213,2.5761278591957684,['NFKBIA'],0.9682678160400457,0,0,1
117,Type III interferon signaling WP2113,0.36079390645232967,2.5269821502698213,2.5761278591957684,['JAK1'],0.9682678160400457,0,0,1
118,Vitamin B12 Disorders WP4271,0.36079390645232967,2.5269821502698213,2.5761278591957684,['MMAB'],0.9682678160400457,0,0,1
119,Estrogen metabolism WP697,0.36079390645232967,2.5269821502698213,2.5761278591957684,['SULT1A1'],0.9682678160400457,0,0,1
120,Farnesoid X receptor pathway WP2879,0.36079390645232967,2.5269821502698213,2.5761278591957684,['IRS2'],0.9682678160400457,0,0,1
121,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.36079390645232967,2.5269821502698213,2.5761278591957684,['ALDH1A1'],0.9682678160400457,0,0,1
122,Insulin signaling in adipocytes (diabetic condition) WP3635,0.36079390645232967,2.5269821502698213,2.5761278591957684,['IRS1'],0.9682678160400457,0,0,1
123,Insulin signaling in adipocytes (normal condition) WP3634,0.36079390645232967,2.5269821502698213,2.5761278591957684,['IRS1'],0.9682678160400457,0,0,1
124,Nephrogenesis WP5052,0.36079390645232967,2.5269821502698213,2.5761278591957684,['NOTCH2'],0.9682678160400457,0,0,1
125,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,0.36079390645232967,2.5269821502698213,2.5761278591957684,['NFKBIA'],0.9682678160400457,0,0,1
126,Role of Osx and miRNAs in tooth development WP3971,0.36079390645232967,2.5269821502698213,2.5761278591957684,['NOTCH2'],0.9682678160400457,0,0,1
127,Male infertility WP4673,0.3754762519654596,1.2301361511887827,1.2049922341261292,"['PIWIL2', 'PON2', 'EP300', 'CHD2', 'MLH3', 'PUM2']",0.9682678160400457,0,0,6
128,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.3766968677984796,1.5962724767029794,1.5584639316931301,"['SMAD2', 'MFGE8']",0.9682678160400457,0,0,2
129,Hedgehog Signaling Pathway WP4249,0.3870294112513141,1.3787311315401203,1.308766856058388,"['GRK3', 'FBXL17', 'GLI1']",0.9682678160400457,0,0,3
130,IL-6 signaling pathway WP364,0.3870294112513141,1.3787311315401203,1.308766856058388,"['NCOA1', 'SHC1', 'JAK1']",0.9682678160400457,0,0,3
131,TLR4 Signaling and Tolerance WP3851,0.39913975586178246,1.5163341645885287,1.3926674970313948,"['NFKBIA', 'INPP5D']",0.9682678160400457,0,0,2
132,NRF2-ARE regulation WP4357,0.39913975586178246,1.5163341645885287,1.3926674970313948,"['MAF', 'EPHB2']",0.9682678160400457,0,0,2
133,Oxidative Stress WP408,0.39913975586178246,1.5163341645885287,1.3926674970313948,"['TXNRD1', 'GSR']",0.9682678160400457,0,0,2
134,Pre-implantation embryo WP3527,0.39913975586178246,1.5163341645885287,1.3926674970313948,"['H2AFY2', 'SOX8']",0.9682678160400457,0,0,2
135,Supression of HMGB1 mediated inflammation by THBD WP4479,0.40039329352600467,2.1658067959437823,1.9823802458845603,['NFKBIA'],0.9682678160400457,0,0,1
136,Valproic acid pathway WP3871,0.40039329352600467,2.1658067959437823,1.9823802458845603,['IVD'],0.9682678160400457,0,0,1
137,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.40039329352600467,2.1658067959437823,1.9823802458845603,['JAK1'],0.9682678160400457,0,0,1
138,Leptin and adiponectin WP3934,0.40039329352600467,2.1658067959437823,1.9823802458845603,['PRKAG1'],0.9682678160400457,0,0,1
139,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.40039329352600467,2.1658067959437823,1.9823802458845603,['STAG1'],0.9682678160400457,0,0,1
140,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.40345294445727703,1.2638541666666667,1.147194634230514,"['SP3', 'PLCE1', 'PLCD1', 'JAK1']",0.9682678160400457,0,0,4
141,TGF-beta Receptor Signaling WP560,0.4040756893639146,1.3380700594844679,1.2124962904813905,"['SMAD2', 'EP300', 'JAK1']",0.9682678160400457,0,0,3
142,Common Pathways Underlying Drug Addiction WP2636,0.4040756893639146,1.3380700594844679,1.2124962904813905,"['RAP1A', 'ADCY8', 'ACTG1']",0.9682678160400457,0,0,3
143,Copper homeostasis WP3286,0.4040756893639146,1.3380700594844679,1.2124962904813905,"['BACE1', 'ADAM10', 'MAPT']",0.9682678160400457,0,0,3
144,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.4055285707359863,1.1378301886792452,1.026964509372061,"['NFKBIA', 'VAV3', 'RPS6KA3', 'CDKL5', 'RAP1A', 'IRS1', 'SHC1', 'IRS2', 'MAPT']",0.9682678160400457,0,0,9
145,AGE/RAGE pathway WP2324,0.4176558481374777,1.2379591836734694,1.080859087424703,"['SMAD2', 'NFKBIA', 'IRS1', 'SHC1']",0.9682678160400457,0,0,4
146,IL-3 signaling pathway WP286,0.4209812504219831,1.2997324772605672,1.1244856248970332,"['SHC1', 'INPP5D', 'JAK1']",0.9682678160400457,0,0,3
147,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.4211967278893351,1.4440090250564066,1.248570009538461,"['PLOD2', 'TMEM38B']",0.9682678160400457,0,0,2
148,Photodynamic therapy-induced unfolded protein response WP3613,0.4211967278893351,1.4440090250564066,1.248570009538461,"['DNAJB11', 'CALR']",0.9682678160400457,0,0,2
149,ESC Pluripotency Pathways WP3931,0.43163198957077914,1.1518035595317409,0.9677245373796267,"['PDGFRB', 'FZD3', 'FZD7', 'FZD9', 'WNT7A', 'JAK1']",0.9682678160400457,0,0,6
150,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.4317795880841271,1.2131,1.0188099448924788,"['FZD3', 'SHC1', 'FZD7', 'FZD9']",0.9682678160400457,0,0,4
151,MAPK Signaling Pathway WP382,0.43273242905144516,1.0835289868159654,0.9076025491530987,"['PDGFRB', 'CACNA1B', 'CACNA1D', 'HSPA2', 'DUSP16', 'RPS6KA3', 'CACNG7', 'PPP3CB', 'MRAS', 'RAP1A', 'NF1', 'FLNA', 'MAPT']",0.9682678160400457,0,0,13
152,Transcriptional cascade regulating adipogenesis WP4211,0.4375423206092869,1.8949252801992529,1.5663108343229906,['KLF2'],0.9682678160400457,0,0,1
153,Neuroinflammation WP4919,0.4375423206092869,1.8949252801992529,1.5663108343229906,['NFKBIA'],0.9682678160400457,0,0,1
154,NLR Proteins WP288,0.4375423206092869,1.8949252801992529,1.5663108343229906,['EPHB2'],0.9682678160400457,0,0,1
155,Complement system WP2806,0.4377219965428502,1.263524760715772,1.043887870400389,"['GNAI3', 'CD59', 'CALR']",0.9682678160400457,0,0,3
156,Regulation of Microtubule Cytoskeleton WP2038,0.4377219965428502,1.263524760715772,1.043887870400389,"['TESK2', 'MAPT', 'EPHB2']",0.9682678160400457,0,0,3
157,Wnt signaling WP428,0.4427887679629361,1.137312030075188,0.9265253984742423,"['FZD3', 'PPP3CB', 'FZD7', 'FZD9', 'WNT7A', 'CXXC4']",0.9682678160400457,0,0,6
158,Aryl Hydrocarbon Receptor Pathway WP2873,0.44282952121445535,1.378258898209023,1.1226889171242584,"['NCOA1', 'EP300']",0.9682678160400457,0,0,2
159,TYROBP causal network in microglia WP3945,0.44282952121445535,1.378258898209023,1.1226889171242584,"['MAF', 'ADAP2']",0.9682678160400457,0,0,2
160,ATM Signaling Network in Development and Disease  WP3878,0.45427586901818473,1.229274218038263,0.9699595893887217,"['CHEK2', 'PPM1D', 'HMGN1']",0.9682678160400457,0,0,3
161,Mesodermal commitment pathway WP2857,0.4562017909690148,1.1056435591802594,0.8677312259877704,"['SMAD2', 'VAV3', 'ATP8B2', 'SESN1', 'TEAD1', 'PIAS1', 'PARP8']",0.9682678160400457,0,0,7
162,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.46290933464574624,1.1314516279677955,0.8714712728901738,"['PDGFRB', 'MRAS', 'SHC1', 'NF1', 'JAK1']",0.9682678160400457,0,0,5
163,Chemokine signaling pathway WP3929,0.4663679861761393,1.0941546262401531,0.8345995793617558,"['NFKBIA', 'VAV3', 'RAP1A', 'SHC1', 'PARD3', 'GNAI3', 'ADCY8']",0.9682678160400457,0,0,7
164,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.47062278005079755,1.1968263355016755,0.9020460911086992,"['SMAD2', 'EP300', 'JAK1']",0.9682678160400457,0,0,3
165,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.47062278005079755,1.1968263355016755,0.9020460911086992,"['EIF4A1', 'RPS6KA2', 'EIF4G3']",0.9682678160400457,0,0,3
166,TCA cycle in senescence WP5050,0.4723924354862313,1.6842396568423965,1.2630874593162094,['ME2'],0.9682678160400457,0,0,1
167,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.4723924354862313,1.6842396568423965,1.2630874593162094,['GRM8'],0.9682678160400457,0,0,1
168,Major receptors targeted by epinephrine and norepinephrine WP4589,0.4723924354862313,1.6842396568423965,1.2630874593162094,['ADCY8'],0.9682678160400457,0,0,1
169,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.4723924354862313,1.6842396568423965,1.2630874593162094,['RNASEH2C'],0.9682678160400457,0,0,1
170,Pathways in clear cell renal cell carcinoma WP4018,0.4750729510407772,1.1147206066406539,0.8296719509266801,"['PDGFRB', 'EP300', 'PLOD2', 'SDSL', 'PFKP']",0.9682678160400457,0,0,5
171,Pathways Regulating Hippo Signaling WP4540,0.4750729510407772,1.1147206066406539,0.8296719509266801,"['PDGFRB', 'SMAD2', 'PRKAG1', 'GNAI3', 'TEAD1']",0.9682678160400457,0,0,5
172,Vitamin A and carotenoid metabolism WP716,0.4846999253929989,1.2631961762261015,0.9148386171235859,"['SULT1A1', 'ALDH1A1']",0.9682678160400457,0,0,2
173,Hematopoietic Stem Cell Differentiation WP2849,0.4846999253929989,1.2631961762261015,0.9148386171235859,"['THRB', 'MXI1']",0.9682678160400457,0,0,2
174,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.4846999253929989,1.2631961762261015,0.9148386171235859,"['RAP1A', 'TEAD1']",0.9682678160400457,0,0,2
175,Oxysterols derived from cholesterol WP4545,0.4846999253929989,1.2631961762261015,0.9148386171235859,"['ACOT9', 'AMACR']",0.9682678160400457,0,0,2
176,Cytosolic DNA-sensing pathway WP4655,0.48674453933520134,1.1660424469413233,0.8395690475535826,"['NFKBIA', 'IL33', 'TRIM25']",0.9682678160400457,0,0,3
177,Proteasome Degradation WP183,0.5007092015634279,1.1023636363636364,0.7625377583257927,"['PSMD6', 'PSMD13', 'PSME2', 'HLA-E']",0.9682678160400457,0,0,4
178,Exercise-induced Circadian Regulation WP410,0.5026247771229395,1.1367977528089888,0.7820160849864319,"['BTG1', 'VAPA', 'CRY2']",0.9682678160400457,0,0,3
179,Melatonin metabolism and effects WP3298,0.504889608292722,1.212568578553616,0.8286881262839597,"['SULT1A1', 'CRY2']",0.9682678160400457,0,0,2
180,Glutathione metabolism WP100,0.5050857364781004,1.5156911581569117,1.0352581194467814,['GSR'],0.9682678160400457,0,0,1
181,Homologous recombination WP186,0.5050857364781004,1.5156911581569117,1.0352581194467814,['RAD54B'],0.9682678160400457,0,0,1
182,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.5050857364781004,1.5156911581569117,1.0352581194467814,['JAK1'],0.9682678160400457,0,0,1
183,Nucleotide Excision Repair WP4753,0.5182488643145757,1.1089796291221339,0.7289319986585154,"['DDB1', 'GTF2H3', 'RAD23B']",0.9682678160400457,0,0,3
184,Ras signaling WP4223,0.5206544990093382,1.025507164136757,0.6693163321871637,"['PDGFRB', 'SYNGAP1', 'RAP1A', 'MRAS', 'SHC1', 'NF1', 'PLCE1', 'PLA2G5', 'PAK4']",0.9682678160400457,0,0,9
185,VEGFA-VEGFR2 Signaling Pathway WP3888,0.5237005561156004,1.004335681366164,0.6496396871921113,"['ACOT9', 'SHC1', 'LARP7', 'ADAM10', 'PDE4DIP', 'AP2A1', 'PLA2G5', 'IQGAP1', 'RPL10A', 'PRDX6', 'ACTG1', 'NFKBIA', 'MOV10', 'RAP1A', 'TFCP2', 'CSRP1', 'CTNNA1', 'CAPN2', 'RICTOR', 'CALR', 'EPHB2', 'EIF3D', 'FARSB']",0.9682678160400457,0,0,23
186,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.5245581706129291,1.1658354114713216,0.7521957839399327,"['NFKBIA', 'JAK1']",0.9682678160400457,0,0,2
187,Fatty acid transporters WP5061,0.5357555489115304,1.3777878410506057,0.8598460984616018,['FABP5'],0.9682678160400457,0,0,1
188,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.5357555489115304,1.3777878410506057,0.8598460984616018,['NFKBIA'],0.9682678160400457,0,0,1
189,miRNA regulation of prostate cancer signaling pathways WP3981,0.5436926819237224,1.1225639604691975,0.6840580519014988,"['PDGFRB', 'NFKBIA']",0.9682678160400457,0,0,2
190,Neovascularisation processes WP4331,0.5436926819237224,1.1225639604691975,0.6840580519014988,"['SMAD2', 'EPHB2']",0.9682678160400457,0,0,2
191,Prion disease pathway WP3995,0.5436926819237224,1.1225639604691975,0.6840580519014988,"['EP300', 'CHD2']",0.9682678160400457,0,0,2
192,Proximal tubule transport WP4917,0.5436926819237224,1.1225639604691975,0.6840580519014988,"['SLC13A3', 'SLC47A1']",0.9682678160400457,0,0,2
193,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.5486782840381493,1.0572249804024039,0.6345919074582277,"['SYNGAP1', 'PRKAG1', 'NF1']",0.9682678160400457,0,0,3
194,G1 to S cell cycle control WP45,0.5486782840381493,1.0572249804024039,0.6345919074582277,"['TFDP2', 'ORC3', 'MCM5']",0.9682678160400457,0,0,3
195,Breast cancer pathway WP4262,0.5551898504658092,1.0005089841623067,0.5887446600800865,"['NOTCH2', 'NCOA1', 'FZD3', 'SHC1', 'FZD7', 'FZD9', 'WNT7A']",0.9682678160400457,0,0,7
196,Neural Crest Cell Migration during Development WP4564,0.5622838046486952,1.0823833273957961,0.6231806486917485,"['EPHB2', 'PAK4']",0.9682678160400457,0,0,2
197,Selenium Micronutrient Network WP15,0.5634623238833752,1.0331120190670753,0.5926496775981601,"['TXNRD1', 'GSR', 'SELENOI']",0.9682678160400457,0,0,3
198,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.564526966312125,1.262868410128684,0.7220666417199195,['NRF1'],0.9682678160400457,0,0,1
199,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.564526966312125,1.262868410128684,0.7220666417199195,['NFKBIA'],0.9682678160400457,0,0,1
200,Canonical and non-canonical TGF-B signaling WP3874,0.564526966312125,1.262868410128684,0.7220666417199195,['SMAD2'],0.9682678160400457,0,0,1
201,Type II diabetes mellitus WP1584,0.564526966312125,1.262868410128684,0.7220666417199195,['IRS1'],0.9682678160400457,0,0,1
202,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.564526966312125,1.262868410128684,0.7220666417199195,['UNC13D'],0.9682678160400457,0,0,1
203,Hedgehog Signaling Pathway Netpath WP47,0.564526966312125,1.262868410128684,0.7220666417199195,['GLI1'],0.9682678160400457,0,0,1
204,Hypertrophy Model WP516,0.564526966312125,1.262868410128684,0.7220666417199195,['ADAM10'],0.9682678160400457,0,0,1
205,Omega-3/Omega-6 FA synthesis WP4723,0.564526966312125,1.262868410128684,0.7220666417199195,['PLA2G5'],0.9682678160400457,0,0,1
206,Omega-9 FA synthesis WP4724,0.564526966312125,1.262868410128684,0.7220666417199195,['ELOVL6'],0.9682678160400457,0,0,1
207,PPAR-alpha pathway WP2878,0.564526966312125,1.262868410128684,0.7220666417199195,['CPT2'],0.9682678160400457,0,0,1
208,Neural Crest Differentiation WP2064,0.5657485894693719,1.0100833333333334,0.5753490096771577,"['NOTCH2', 'PRTG', 'FZD3', 'DCT']",0.9682678160400457,0,0,4
209,Osteoblast differentiation WP4787,0.5684241838033268,0.9967228772808115,0.5630361313842946,"['NOTCH2', 'FZD3', 'FZD7', 'FZD9', 'WNT7A']",0.9682678160400457,0,0,5
210,Calcium Regulation in the Cardiac Cell WP536,0.5740613857617036,0.9818183930480041,0.5449278082443068,"['PKIB', 'STIM2', 'CACNA1B', 'GNAI3', 'CACNA1D', 'CALR', 'ADCY8']",0.9682678160400457,0,0,7
211,Fragile X Syndrome  WP4549,0.5740613857617036,0.9818183930480041,0.5449278082443068,"['CYFIP2', 'EIF4A1', 'SYNGAP1', 'KCND2', 'SHC1', 'NF1', 'AP2A1']",0.9682678160400457,0,0,7
212,CAMKK2  Pathway WP4874,0.5803254000204299,1.0449737724653883,0.5686395095253062,"['MAF', 'EP300']",0.9682678160400457,0,0,2
213,Tumor suppressor activity of SMARCB1 WP4204,0.5803254000204299,1.0449737724653883,0.5686395095253062,"['SMARCC2', 'GLI1']",0.9682678160400457,0,0,2
214,16p11.2 proximal deletion syndrome WP4949,0.5904218150347278,0.9773387096774193,0.5149774137327101,"['PPP4R1', 'PPP4R2', 'PPP4R4', 'KCTD13']",0.9682678160400457,0,0,4
215,DNA IR-damage and cellular response via ATR WP4016,0.5904218150347278,0.9773387096774193,0.5149774137327101,"['SMARCC2', 'CHEK2', 'PPM1D', 'MCPH1']",0.9682678160400457,0,0,4
216,Leptin signaling pathway WP2034,0.5904218150347278,0.9773387096774193,0.5149774137327101,"['NCOA1', 'IRS1', 'SHC1', 'JAK1']",0.9682678160400457,0,0,4
217,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.5915173576017148,1.165628891656289,0.6120300608673463,['SMAD2'],0.9682678160400457,0,0,1
218,Cori Cycle WP1946,0.5915173576017148,1.165628891656289,0.6120300608673463,['PFKP'],0.9682678160400457,0,0,1
219,IL-9 signaling pathway WP22,0.5915173576017148,1.165628891656289,0.6120300608673463,['JAK1'],0.9682678160400457,0,0,1
220,Imatinib and Chronic Myeloid Leukemia WP3640,0.5915173576017148,1.165628891656289,0.6120300608673463,['PDGFRB'],0.9682678160400457,0,0,1
221,Monoamine GPCRs WP58,0.5915173576017148,1.165628891656289,0.6120300608673463,['HRH1'],0.9682678160400457,0,0,1
222,SARS coronavirus and innate immunity WP4912,0.5915173576017148,1.165628891656289,0.6120300608673463,['JAK1'],0.9682678160400457,0,0,1
223,Signaling of Hepatocyte Growth Factor Receptor WP313,0.5978141684578109,1.010058187863674,0.5196500179175504,"['RAP1A', 'DOCK1']",0.9682678160400457,0,0,2
224,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.5978141684578109,1.010058187863674,0.5196500179175504,"['NFKBIA', 'JAK1']",0.9682678160400457,0,0,2
225,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.5978141684578109,1.010058187863674,0.5196500179175504,"['SHC1', 'AP2A1']",0.9682678160400457,0,0,2
226,NO/cGMP/PKG mediated Neuroprotection WP4008,0.5978141684578109,1.010058187863674,0.5196500179175504,"['NFKBIA', 'ACTN2']",0.9682678160400457,0,0,2
227,p38 MAPK Signaling Pathway WP400,0.5978141684578109,1.010058187863674,0.5196500179175504,"['SHC1', 'HMGN1']",0.9682678160400457,0,0,2
228,Allograft Rejection WP2328,0.6147493222995317,0.9773952216233609,0.4755425555853615,"['COL5A1', 'HLA-E']",0.9682678160400457,0,0,2
229,Disruption of postsynaptic signaling by CNV WP4875,0.6147493222995317,0.9773952216233609,0.4755425555853615,"['SYNGAP1', 'DLGAP1']",0.9682678160400457,0,0,2
230,Neural Crest Cell Migration in Cancer WP4565,0.6147493222995317,0.9773952216233609,0.4755425555853615,"['EPHB2', 'PAK4']",0.9682678160400457,0,0,2
231,Parkinson's disease pathway WP2371,0.6147493222995317,0.9773952216233609,0.4755425555853615,"['PRKN', 'GPR37']",0.9682678160400457,0,0,2
232,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.6168368441719378,1.0822807329656645,0.5229047198407837,['ACO1'],0.9682678160400457,0,0,1
233,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.6168368441719378,1.0822807329656645,0.5229047198407837,['LPP'],0.9682678160400457,0,0,1
234,Overview of interferons-mediated signaling pathway WP4558,0.6168368441719378,1.0822807329656645,0.5229047198407837,['JAK1'],0.9682678160400457,0,0,1
235,p53 transcriptional gene network WP4963,0.6195440608857116,0.946707240948814,0.4532564052339431,"['ZMAT3', 'SESN1', 'FANCC']",0.9682678160400457,0,0,3
236,DNA Replication WP466,0.6311322882256868,0.9467736907730673,0.4357429245043104,"['ORC3', 'MCM5']",0.9682678160400457,0,0,2
237,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.6311322882256868,0.9467736907730673,0.4357429245043104,"['RPS6KA3', 'RPS6KA2']",0.9682678160400457,0,0,2
238,Ciliopathies WP4803,0.6351105313114143,0.9267616480554486,0.4207092240263444,"['CSPP1', 'NME9', 'EFHC1', 'BBS9', 'PKD1L1', 'BBIP1', 'CCNQ', 'TOPORS', 'GLIS2']",0.9682678160400457,0,0,9
239,Glioblastoma signaling pathways WP2261,0.637201301305455,0.9178030303030303,0.41362597844235743,"['PDGFRB', 'IRS1', 'NF1', 'EP300']",0.9682678160400457,0,0,4
240,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.640588746304582,1.0100456621004565,0.449841621905444,['RAP1A'],0.9682678160400457,0,0,1
241,miRNA targets in ECM and membrane receptors WP2911,0.640588746304582,1.0100456621004565,0.449841621905444,['COL5A1'],0.9682678160400457,0,0,1
242,Acute viral myocarditis WP4298,0.6456812044673647,0.908689138576779,0.39750550804621027,"['SGCD', 'CHRAC1', 'JAK1']",0.9682678160400457,0,0,3
243,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.6456812044673647,0.908689138576779,0.39750550804621027,"['CTSL', 'PLCE1', 'TLN1']",0.9682678160400457,0,0,3
244,Regulatory circuits of the STAT3 signaling pathway WP4538,0.6456812044673647,0.908689138576779,0.39750550804621027,"['PDGFRB', 'RICTOR', 'JAK1']",0.9682678160400457,0,0,3
245,Urea cycle and metabolism of amino groups WP497,0.6628700029992517,0.9468399750933998,0.38931823522454495,['ODC1'],0.9682678160400457,0,0,1
246,Microglia Pathogen Phagocytosis Pathway WP3937,0.6628700029992517,0.9468399750933998,0.38931823522454495,['VAV3'],0.9682678160400457,0,0,1
247,Mitochondrial Gene Expression WP391,0.6628700029992517,0.9468399750933998,0.38931823522454495,['NRF1'],0.9682678160400457,0,0,1
248,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.6628700029992517,0.9468399750933998,0.38931823522454495,['CPT2'],0.9682678160400457,0,0,1
249,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.6628700029992517,0.9468399750933998,0.38931823522454495,['SOX8'],0.9682678160400457,0,0,1
250,3q29 copy number variation syndrome WP4906,0.6705206323669529,0.8735955056179775,0.3491768269448845,"['FBXW7', 'ADAM10', 'PIGM']",0.9682678160400457,0,0,3
251,MET in type 1 papillary renal cell carcinoma WP4205,0.6705206323669529,0.8735955056179775,0.3491768269448845,"['ALK', 'RAP1A', 'PAK4']",0.9682678160400457,0,0,3
252,DNA Repair Pathways Full Network WP4946,0.6833281148103959,0.8731203007518797,0.3324668637299757,"['DDB1', 'RAP1A', 'FANCC', 'GTF2H3', 'RAD23B', 'RAD54B']",0.9682678160400457,0,0,6
253,Ebstein-Barr virus LMP1 signaling WP262,0.6837715656955756,0.8910702512636437,0.3387237691200511,['NFKBIA'],0.9682678160400457,0,0,1
254,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.6837715656955756,0.8910702512636437,0.3387237691200511,['MRAS'],0.9682678160400457,0,0,1
255,One-carbon metabolism WP241,0.6837715656955756,0.8910702512636437,0.3387237691200511,['CHDH'],0.9682678160400457,0,0,1
256,Notch Signaling WP268,0.691233836794451,0.8412995289553893,0.31067265785134035,"['NOTCH2', 'DTX4']",0.9682678160400457,0,0,2
257,Nonalcoholic fatty liver disease WP4396,0.7017600787387127,0.8610133529189746,0.30493967615449413,"['NDUFA7', 'UQCRB', 'IRS1', 'PRKAG1', 'IRS2', 'UQCRC2', 'UQCR10']",0.9682678160400457,0,0,7
258,1q21.1 copy number variation syndrome WP4905,0.7033787674287411,0.8414971634149716,0.2960889773597947,['PRKAG1'],0.9682678160400457,0,0,1
259,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.7033787674287411,0.8414971634149716,0.2960889773597947,['NFKBIA'],0.9682678160400457,0,0,1
260,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.7033787674287411,0.8414971634149716,0.2960889773597947,['JAK1'],0.9682678160400457,0,0,1
261,Vitamin D in inflammatory diseases WP4482,0.7033787674287411,0.8414971634149716,0.2960889773597947,['NFKBIA'],0.9682678160400457,0,0,1
262,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.7033787674287411,0.8414971634149716,0.2960889773597947,['H2AFY2'],0.9682678160400457,0,0,1
263,Hippo-Yap signaling pathway WP4537,0.7033787674287411,0.8414971634149716,0.2960889773597947,['TEAD1'],0.9682678160400457,0,0,1
264,Peptide GPCRs WP24,0.7033787674287411,0.8414971634149716,0.2960889773597947,['EDNRA'],0.9682678160400457,0,0,1
265,Splicing factor NOVA regulated synaptic proteins WP4148,0.7049371647820001,0.8184943047785941,0.28618375742383956,"['CADM3', 'STX2']",0.9682678160400457,0,0,2
266,Glycogen Synthesis and Degradation WP500,0.7049371647820001,0.8184943047785941,0.28618375742383956,"['PYGB', 'PPP2R2B']",0.9682678160400457,0,0,2
267,Netrin-UNC5B signaling pathway WP4747,0.7049371647820001,0.8184943047785941,0.28618375742383956,"['INPP5D', 'RLF']",0.9682678160400457,0,0,2
268,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.7053427277306205,0.8257405515832482,0.2882424563485429,"['RAP1A', 'GNAI3', 'JAK1']",0.9682678160400457,0,0,3
269,Pancreatic adenocarcinoma pathway WP4263,0.7102989471839638,0.8293150684931507,0.2836832624378676,"['SMAD2', 'JAK1', 'ARHGEF6', 'PAK4']",0.9682678160400457,0,0,4
270,MECP2 and Associated Rett Syndrome WP3584,0.7163052262914745,0.810928303905832,0.270565344001631,"['CSRP1', 'SP3', 'NF1']",0.9682678160400457,0,0,3
271,Interleukin-11 Signaling Pathway WP2332,0.7181298495907354,0.7968893555584723,0.26385395227231434,"['JAK1', 'PIAS1']",0.9682678160400457,0,0,2
272,Glycerolipids and Glycerophospholipids WP4722,0.7217716697270772,0.797142295339844,0.2599054051945509,['DGKZ'],0.9682678160400457,0,0,1
273,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.7217716697270772,0.797142295339844,0.2599054051945509,['GLI1'],0.9682678160400457,0,0,1
274,IL-7 signaling pathway WP205,0.7217716697270772,0.797142295339844,0.2599054051945509,['JAK1'],0.9682678160400457,0,0,1
275,Modulators of TCR signaling and T cell activation WP5072,0.7308225047157668,0.7763923524522028,0.24346473212048364,"['NFKBIA', 'DGKZ']",0.9682678160400457,0,0,2
276,One-carbon metabolism and related pathways WP3940,0.7308225047157668,0.7763923524522028,0.24346473212048364,"['CHDH', 'GSR']",0.9682678160400457,0,0,2
277,T-cell receptor (TCR) signaling pathway WP69,0.7372778455802563,0.7828361100348702,0.2386009800218362,"['VAV3', 'NFKBIA', 'SHC1']",0.9682678160400457,0,0,3
278,Head and Neck Squamous Cell Carcinoma WP4674,0.7372778455802563,0.7828361100348702,0.2386009800218362,"['NOTCH2', 'SESN1', 'RICTOR']",0.9682678160400457,0,0,3
279,Sphingolipid Metabolism (general overview) WP4725,0.7390253877734287,0.7572229140722292,0.22900162867232854,['DEGS2'],0.9682678160400457,0,0,1
280,Differentiation Pathway WP2848,0.7390253877734287,0.7572229140722292,0.22900162867232854,['ALK'],0.9682678160400457,0,0,1
281,Fluoropyrimidine Activity WP1601,0.7390253877734287,0.7572229140722292,0.22900162867232854,['UPP2'],0.9682678160400457,0,0,1
282,SARS-CoV-2 mitochondrial interactions WP5038,0.7390253877734287,0.7572229140722292,0.22900162867232854,['CTSL'],0.9682678160400457,0,0,1
283,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.7430263876696314,0.7569201995012469,0.22482325329444952,"['SMAD2', 'ADCY8']",0.9682678160400457,0,0,2
284,Eukaryotic Transcription Initiation WP405,0.7430263876696314,0.7569201995012469,0.22482325329444952,"['POLR1A', 'GTF2H3']",0.9682678160400457,0,0,2
285,Pathogenic Escherichia coli infection WP2272,0.7430263876696314,0.7569201995012469,0.22482325329444952,"['ARHGEF2', 'ACTG1']",0.9682678160400457,0,0,2
286,22q11.2 copy number variation syndrome WP4657,0.7469495218983059,0.785974025974026,0.22931395094348406,"['PRKN', 'XPO1', 'SNAP29', 'PAK4']",0.9682678160400457,0,0,4
287,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.7534547450869946,0.8394983886787165,0.23765051144889163,"['PDGFRB', 'COL5A1', 'CAB39L', 'IRS1', 'PPP2R2B', 'COL11A1', 'ITGA7', 'IRS2', 'HIF3A', 'JAK1', 'CREB5']",0.9682678160400457,0,0,11
288,Sphingolipid Metabolism (integrated pathway) WP4726,0.7552103955782623,0.7211053786396252,0.20245675210796987,['DEGS2'],0.9682678160400457,0,0,1
289,Type II interferon signaling (IFNG) WP619,0.7552103955782623,0.7211053786396252,0.20245675210796987,['JAK1'],0.9682678160400457,0,0,1
290,Vitamin B12 metabolism WP1533,0.7552103955782623,0.7211053786396252,0.20245675210796987,['MMAB'],0.9682678160400457,0,0,1
291,Estrogen signaling pathway WP712,0.7552103955782623,0.7211053786396252,0.20245675210796987,['GPER1'],0.9682678160400457,0,0,1
292,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.7552103955782623,0.7211053786396252,0.20245675210796987,['NFKBIA'],0.9682678160400457,0,0,1
293,Regulation of toll-like receptor signaling pathway WP1449,0.7638980753663418,0.7659493670886076,0.20628617896641288,"['NFKBIA', 'RNF31', 'SFTPD', 'ZMYND11']",0.9682678160400457,0,0,4
294,Circadian rhythm related genes WP3594,0.765023614974986,0.8017090604919965,0.21473663052669398,"['KCND2', 'CIPC', 'CRY2', 'ADORA1', 'EP300', 'RORA', 'PTGDS']",0.9682678160400457,0,0,7
295,Hepatitis B infection WP4666,0.7676712694481898,0.7888852566198103,0.20857626981599342,"['SMAD2', 'DDB1', 'EP300', 'HSPG2', 'JAK1', 'CREB5']",0.9682678160400457,0,0,6
296,Cell migration and invasion through p75NTR WP4561,0.7703928124911872,0.6882712555190762,0.179538824998204,['PARD3'],0.9682678160400457,0,0,1
297,Endothelin Pathways WP2197,0.7703928124911872,0.6882712555190762,0.179538824998204,['EDNRA'],0.9682678160400457,0,0,1
298,Ethanol effects on histone modifications WP3996,0.7703928124911872,0.6882712555190762,0.179538824998204,['ALDH1A1'],0.9682678160400457,0,0,1
299,miRNAs involvement in the immune response in sepsis WP4329,0.7703928124911872,0.6882712555190762,0.179538824998204,['NFKBIA'],0.9682678160400457,0,0,1
300,MTHFR deficiency WP4288,0.7703928124911872,0.6882712555190762,0.179538824998204,['CHDH'],0.9682678160400457,0,0,1
301,Physiological and pathological hypertrophy of the heart WP1528,0.7703928124911872,0.6882712555190762,0.179538824998204,['PPP3CB'],0.9682678160400457,0,0,1
302,PPAR signaling pathway WP3942,0.7768252030570435,0.7039378298439947,0.17777240169441197,"['CPT2', 'FABP5']",0.9682678160400457,0,0,2
303,Insulin Signaling WP481,0.7837936940069321,0.7836981272363958,0.19091626085485458,"['RPS6KA3', 'IRS1', 'SHC1', 'RPS6KA2', 'IRS2', 'MAP4K5', 'RHOQ']",0.9682678160400457,0,0,7
304,Sphingolipid pathway WP1422,0.7846346721141773,0.6582922735394445,0.15966026959519805,['PLPP1'],0.9682678160400457,0,0,1
305,Tryptophan metabolism WP465,0.7846346721141773,0.6582922735394445,0.15966026959519805,['ALDH1A1'],0.9682678160400457,0,0,1
306,Glycerophospholipid Biosynthetic Pathway WP2533,0.7846346721141773,0.6582922735394445,0.15966026959519805,['LPIN2'],0.9682678160400457,0,0,1
307,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.787645064776621,0.7377439024390244,0.17610516194904058,"['NDUFA7', 'UQCRB', 'UQCRC2', 'UQCR10']",0.9682678160400457,0,0,4
308,mRNA Processing WP411,0.7938395403749381,0.7621153724647753,0.17595256990895744,"['NUDT21', 'SNRPD1', 'PRPF40A', 'SNRPF', 'SREK1', 'PTBP2']",0.9682678160400457,0,0,6
309,DNA IR-double strand breaks and cellular response via ATM WP3959,0.7971391823922758,0.6725408700471045,0.15248248958319605,"['CHEK2', 'MCPH1']",0.9682678160400457,0,0,2
310,Signal transduction through IL1R WP4496,0.7979941740453877,0.6308115400581153,0.1423451360658806,['NFKBIA'],0.9682678160400457,0,0,1
311,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.7979941740453877,0.6308115400581153,0.1423451360658806,['SMAD2'],0.9682678160400457,0,0,1
312,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.8011008439937132,0.69812734082397,0.15482261284439763,"['THRB', 'ADCY8', 'MAP4K5']",0.9682678160400457,0,0,3
313,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.8066692410568692,0.6578662040550797,0.14133699965041857,"['VAV3', 'CTNNA1']",0.9682678160400457,0,0,2
314,GABA receptor Signaling WP4159,0.810525921164746,0.6055292652552926,0.1272047175438431,['AP2A1'],0.9682678160400457,0,0,1
315,Nanoparticle-mediated activation of receptor signaling WP2643,0.810525921164746,0.6055292652552926,0.1272047175438431,['TLN1'],0.9682678160400457,0,0,1
316,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.810525921164746,0.6055292652552926,0.1272047175438431,['EGLN1'],0.9682678160400457,0,0,1
317,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.810525921164746,0.6055292652552926,0.1272047175438431,['RICTOR'],0.9682678160400457,0,0,1
318,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.810525921164746,0.6055292652552926,0.1272047175438431,['CREB5'],0.9682678160400457,0,0,1
319,TGF-beta Signaling Pathway WP366,0.812854073750767,0.7266896120150188,0.15057275937561201,"['SMAD2', 'SHC1', 'EP300', 'NEDD4L', 'PIAS1']",0.9682678160400457,0,0,5
320,DNA damage response WP707,0.8157987013611614,0.643815991935056,0.13107298094136005,"['SESN1', 'CHEK2']",0.9682678160400457,0,0,2
321,Joubert Syndrome WP4656,0.8167627975295815,0.677175918161999,0.13706484795980658,"['CSPP1', 'BBS9', 'FLNA']",0.9682678160400457,0,0,3
322,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.8190219670229315,0.7197091602598487,0.14368588456562192,"['THRB', 'DEAF1', 'SP3', 'EP300', 'RORA']",0.9682678160400457,0,0,5
323,BDNF-TrkB Signaling WP3676,0.8222811410236394,0.5821917808219178,0.11391916673830903,['SHC1'],0.9682678160400457,0,0,1
324,IL17 signaling pathway WP2112,0.8222811410236394,0.5821917808219178,0.11391916673830903,['JAK1'],0.9682678160400457,0,0,1
325,Lipid Metabolism Pathway WP3965,0.8222811410236394,0.5821917808219178,0.11391916673830903,['PRKAG1'],0.9682678160400457,0,0,1
326,B Cell Receptor Signaling Pathway WP23,0.8241932964320957,0.667162370566204,0.12899597346778235,"['NFKBIA', 'SHC1', 'INPP5D']",0.9682678160400457,0,0,3
327,Mitochondrial complex I assembly model OXPHOS system WP4324,0.8245405620966014,0.6303512053200333,0.12161299125633077,"['NDUFA7', 'NDUFAF2']",0.9682678160400457,0,0,2
328,miRNA regulation of DNA damage response WP1530,0.8329077498708406,0.6174360018321543,0.11288729828210738,"['SESN1', 'CHEK2']",0.972614685562026,0,0,2
329,Autophagy WP4923,0.833307894661215,0.5605829989391633,0.10222347792453637,['PRKAG1'],0.972614685562026,0,0,1
330,IL-1 signaling pathway WP195,0.8409130787229948,0.6050374064837906,0.10483300361560158,"['NFKBIA', 'HSPB2']",0.9785170370594848,0,0,2
331,Development of ureteric collection system WP5053,0.8436512720625334,0.5405177014766056,0.09189668700897674,['GLI1'],0.9787374274078938,0,0,1
332,Fatty acid beta-oxidation WP143,0.853353575437384,0.5218362176321553,0.08275347060215583,['CPT2'],0.9870113643613115,0,0,1
333,Myometrial relaxation and contraction pathways WP289,0.8577301894776689,0.6743362238512426,0.10348747619609913,"['PKIB', 'ADCY8', 'DGKZ', 'PLCD1', 'ACTG1']",0.9890942725508254,0,0,5
334,Vitamin D-sensitive calcium signaling in depression WP4698,0.862454491526615,0.5044001660440016,0.07463755276567467,['GSR'],0.989870237323414,0,0,1
335,Vitamin D Receptor Pathway WP2877,0.863558670581624,0.6127644498431015,0.08988852421018315,"['NINJ1', 'CD9', 'TRAK1']",0.989870237323414,0,0,3
336,AMP-activated protein kinase (AMPK) signaling WP1403,0.8695662756176366,0.5600350974415812,0.07827091147664123,"['PRKAG1', 'SLC2A4RG']",0.9911103741941227,0,0,2
337,Amyotrophic lateral sclerosis (ALS) WP2447,0.8709912530752821,0.48808902100992246,0.06741648803151323,['PPP3CB'],0.9911103741941227,0,0,1
338,Glycolysis and Gluconeogenesis WP534,0.8789987903926588,0.47279732254047324,0.060977501589375364,['PFKP'],0.9911103741941227,0,0,1
339,Hepatitis C and Hepatocellular Carcinoma WP3646,0.8789987903926588,0.47279732254047324,0.060977501589375364,['JAK1'],0.9911103741941227,0,0,1
340,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.8865098735177722,0.45843239367523303,0.055224148723788745,['NFKBIA'],0.9911103741941227,0,0,1
341,Apoptosis WP254,0.887856667470638,0.5304283151769699,0.06309177447915221,"['NFKBIA', 'CRADD']",0.9911103741941227,0,0,2
342,Endometrial cancer WP4155,0.887856667470638,0.5304283151769699,0.06309177447915221,"['CTNNA1', 'CTNNA2']",0.9911103741941227,0,0,2
343,Fas ligand pathway and stress induction of heat shock proteins WP314,0.8935552457731091,0.4449124606255952,0.050073614114040835,['ACTG1'],0.9911103741941227,0,0,1
344,Ferroptosis WP4313,0.8935552457731091,0.4449124606255952,0.050073614114040835,['FTH1'],0.9911103741941227,0,0,1
345,G13 Signaling Pathway WP524,0.8935552457731091,0.4449124606255952,0.050073614114040835,['IQGAP1'],0.9911103741941227,0,0,1
346,Nephrotic syndrome WP4758,0.8935552457731091,0.4449124606255952,0.050073614114040835,['PLCE1'],0.9911103741941227,0,0,1
347,DNA damage response (only ATM dependent) WP710,0.9080868044355007,0.5459139930508551,0.052634464335723136,"['IRS1', 'SHC1', 'WNT7A']",0.9911103741941227,0,0,3
348,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.9131408319108518,0.487450728018663,0.04429228764463365,"['PRKAG1', 'SEC31A']",0.9911103741941227,0,0,2
349,Retinoblastoma gene in cancer WP2446,0.9175098106526461,0.4796738312947789,0.04129608250632966,"['TFDP2', 'HMGB2']",0.9911103741941227,0,0,2
350,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.9176303541651096,0.39794848266369537,0.03420790377393893,['NFKBIA'],0.9911103741941227,0,0,1
351,Metabolic reprogramming in colon cancer WP4290,0.9176303541651096,0.39794848266369537,0.03420790377393893,['PYCR2'],0.9911103741941227,0,0,1
352,7q11.23 copy number variation syndrome WP4932,0.9197108080656725,0.5267398310251721,0.0440860155347965,"['FZD9', 'HSPA2', 'DEK']",0.9911103741941227,0,0,3
353,Endochondral Ossification with Skeletal Dysplasias WP4808,0.9227457293079512,0.38771274387712745,0.031172711496399875,['SLC38A2'],0.9911103741941227,0,0,1
354,Endochondral Ossification WP474,0.9227457293079512,0.38771274387712745,0.031172711496399875,['SLC38A2'],0.9911103741941227,0,0,1
355,Histone Modifications WP2369,0.9227457293079512,0.38771274387712745,0.031172711496399875,['SETBP1'],0.9911103741941227,0,0,1
356,Metapathway biotransformation Phase I and II WP702,0.923276874414145,0.5206423005725601,0.04156085329556398,"['SULT1A1', 'GSR', 'NAT10']",0.9911103741941227,0,0,3
357,Apoptosis Modulation and Signaling WP1772,0.9256351102297321,0.4648379052369077,0.035920428810518504,"['NFKBIA', 'CRADD']",0.9911103741941227,0,0,2
358,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.9275437876941233,0.37798879202988794,0.02843053100107321,['TM7SF2'],0.9911103741941227,0,0,1
359,Phosphodiesterases in neuronal function WP4222,0.9275437876941233,0.37798879202988794,0.02843053100107321,['ADCY8'],0.9911103741941227,0,0,1
360,Gastrin signaling pathway WP4659,0.9299776023175995,0.5088583091360519,0.03694045530042212,"['NFKBIA', 'IRS1', 'SHC1']",0.9911103741941227,0,0,3
361,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.9362653802255891,0.35993002431358595,0.02370366571004076,['PPP1R12A'],0.9911103741941227,0,0,1
362,Corticotropin-releasing hormone signaling pathway WP2355,0.9364198872654341,0.4442203315241309,0.029181413546784756,"['NFKBIA', 'GRK3']",0.9911103741941227,0,0,2
363,Ectoderm Differentiation WP2858,0.9369090256053816,0.5339823008849558,0.03479914200969565,"['ZNF219', 'HMGB2', 'CTNNA2', 'ANKS1B']",0.9911103741941227,0,0,4
364,Pyrimidine metabolism WP4022,0.9485091985131477,0.4194028816846772,0.02217122657412668,"['PNPT1', 'POLR1A']",0.9942153087784896,0,0,2
365,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.9506883981263886,0.3285234717634956,0.01661307952647415,['NFKBIA'],0.9942153087784896,0,0,1
366,RANKL/RANK signaling pathway WP2018,0.9506883981263886,0.3285234717634956,0.01661307952647415,['NFKBIA'],0.9942153087784896,0,0,1
367,Spinal Cord Injury WP2431,0.9511700135096572,0.41362347555768114,0.020707008289947322,"['VCAN', 'PLA2G5']",0.9942153087784896,0,0,2
368,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.9566266334968326,0.3147831050228311,0.01395814590158383,['SMAD2'],0.9942153087784896,0,0,1
369,Glucocorticoid Receptor Pathway WP2880,0.9566266334968326,0.3147831050228311,0.01395814590158383,['MFGE8'],0.9942153087784896,0,0,1
370,Oxidative phosphorylation WP623,0.9593222470484852,0.3083335451241518,0.012804548385344968,['NDUFA7'],0.9942153087784896,0,0,1
371,G Protein Signaling Pathways WP35,0.9605569780125511,0.39200699549826734,0.015775136627222387,"['GNAI3', 'ADCY8']",0.9942153087784896,0,0,2
372,ErbB signaling pathway WP673,0.966434574208977,0.377213216957606,0.01287869149254228,"['SHC1', 'PAK4']",0.9954107673797974,0,0,2
373,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.968531853149617,0.2849691017176155,0.009111575703756973,['NFKBIA'],0.9954107673797974,0,0,1
374,IL-18 signaling pathway WP4754,0.9725749822806518,0.5128588516746412,0.014261632212671276,"['NFKBIA', 'PYGB', 'FBXW7', 'ZNF219', 'DEK', 'KLF2']",0.9954107673797974,0,0,6
375,Toll-like Receptor Signaling Pathway WP75,0.9771720351787573,0.260295443809851,0.006010887452049208,['NFKBIA'],0.9954107673797974,0,0,1
376,Melanoma WP4685,0.9785917938322706,0.2558625493382865,0.005537041033680604,['NF1'],0.9954107673797974,0,0,1
377,PI3K-Akt signaling pathway WP4172,0.9805482170720657,0.5105614500980619,0.010029192682581222,"['PDGFRB', 'IRS1', 'PPP2R2B', 'ITGA7', 'COL9A2', 'JAK1', 'CREB5']",0.9954107673797974,0,0,7
378,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.9834418167737143,0.23953823953823955,0.003999522618957745,['SMAD2'],0.9954107673797974,0,0,1
379,Non-small cell lung cancer WP4255,0.9844719868849604,0.23577599626400997,0.0036898555474721086,['ALK'],0.9954107673797974,0,0,1
380,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9879909203020933,0.22183356530657095,0.0026801423925233536,['PPP3CB'],0.9954107673797974,0,0,1
381,Senescence and Autophagy in Cancer WP615,0.9918333026470684,0.20374608730773114,0.0016707642690289425,['GSN'],0.9954107673797974,0,0,1
382,Small cell lung cancer WP4658,0.9928185518397459,0.19835157632562103,0.0014295909959115799,['NFKBIA'],0.9954107673797974,0,0,1
383,TNF-alpha signaling pathway WP231,0.9928185518397459,0.19835157632562103,0.0014295909959115799,['NFKBIA'],0.9954107673797974,0,0,1
384,Genes related to primary cilium development (based on CRISPR) WP4536,0.9983638409311151,0.15198057788344213,0.00024886805022115,['BBS9'],0.9983638409311151,0,0,1
